# Assess commercial value and delivery feasibility

## Goal

Provide an evidence-led assessment of whether First Month Pet has a commercially credible wedge and can be launched as a dependable paid product. The decision audience is the product owner.

## Confirmed product facts

- The MVP targets English-speaking first-time cat or dog adopters in Europe and North America during the first 30 days after adoption.
- The product offers a free Day 1 preview and safety guidance; a $9.99 one-time, one-profile purchase unlocks the full 30-day plan, personalised tasks, milestones, and source context.
- The repository contains Supabase Auth/Postgres integration, server-side entitlement checks, Creem checkout creation, signed webhook-based fulfilment/refunds, and private funnel-event capture.
- This assessment is based on the current local working tree, including uncommitted application, migration, and product-document changes. The remote deployment is intentionally excluded from functional and UX conclusions.

## Requirements

1. Assess user/problem severity, willingness-to-pay plausibility, market scale, differentiation, and acquisition/retention implications.
2. Assess implementation, operations, trust/safety, legal/policy, payment, data, and go-to-market readiness from repository and production evidence.
3. Separate confirmed facts, external evidence, reasoned inferences, and unknowns.
4. Give a clear recommendation: proceed, narrow and validate, or pause; name the smallest experiments and release gates that could change the decision.

## Out of scope

- Product-code changes, database migrations, deployment, payment configuration, legal-policy drafting, or marketing execution.
- Claiming live payment, email, webhook, database, analytics, or legal compliance without direct production verification.

## Acceptance criteria

- [x] Delivers an explicit commercial verdict with confidence and assumptions.
- [x] Explains the paid value proposition versus free alternatives and incumbent platforms.
- [x] Identifies launch-blocking versus post-validation risks, each tied to repository or external evidence where available.
- [x] Defines measurable funnel thresholds and a minimal validation sequence before spending on broad acquisition.
- [x] States exactly which production conditions were and were not verified.
